🦠microbiology review

Coombs Tests

Written by the Fiveable Content Team • Last updated August 2025
Written by the Fiveable Content Team • Last updated August 2025

Definition

Coombs tests, also known as the antiglobulin test, are a series of laboratory procedures used to detect antibodies or complement components bound to the surface of red blood cells. These tests are primarily employed in the context of immunohematology, particularly in the diagnosis and management of various hypersensitivity reactions.

5 Must Know Facts For Your Next Test

  1. Coombs tests are essential in the diagnosis and management of autoimmune hemolytic anemias, hemolytic disease of the newborn, and transfusion reactions.
  2. The direct Coombs test is used to detect in vivo sensitization of red blood cells, while the indirect Coombs test is used to detect antibodies in the patient's serum that can bind to red blood cells.
  3. Coombs tests can also be used to detect the presence of complement components on the surface of red blood cells, indicating immune-mediated destruction.
  4. The antiglobulin reagent used in Coombs tests contains antibodies against human immunoglobulins (IgG, IgM) or complement components (C3d), which can agglutinate sensitized red blood cells.
  5. Coombs tests are crucial in ensuring the safety and compatibility of blood transfusions, as they can detect the presence of irregular antibodies that may cause hemolytic transfusion reactions.

Review Questions

  • Explain the purpose and principle of the Coombs tests in the context of hypersensitivity reactions.
    • The Coombs tests are used to detect the presence of antibodies or complement components bound to the surface of red blood cells, which is a hallmark of various hypersensitivity reactions. The direct Coombs test identifies in vivo sensitization of the patient's own red blood cells, while the indirect Coombs test detects antibodies in the patient's serum that can bind to and sensitize red blood cells. These tests are crucial in the diagnosis and management of autoimmune hemolytic anemias, hemolytic disease of the newborn, and transfusion reactions, where the immune system mistakenly attacks the patient's own red blood cells or those of a donor.
  • Describe the role of the antiglobulin reagent used in Coombs tests and how it helps in the detection of sensitized red blood cells.
    • The antiglobulin reagent used in Coombs tests contains antibodies against human immunoglobulins (IgG, IgM) or complement components (C3d). When this reagent is added to a sample of red blood cells, it can agglutinate or clump together those cells that have antibodies or complement components bound to their surface. This agglutination reaction indicates the presence of in vivo sensitization, which is a key feature of various hypersensitivity disorders. The ability of the antiglobulin reagent to detect this sensitization is the underlying principle that makes Coombs tests a valuable diagnostic tool in the field of immunohematology.
  • Evaluate the clinical significance of Coombs tests in ensuring the safety and compatibility of blood transfusions, and how they contribute to the prevention of hemolytic transfusion reactions.
    • Coombs tests play a crucial role in ensuring the safety and compatibility of blood transfusions, which is essential for preventing hemolytic transfusion reactions. The indirect Coombs test is used to screen the patient's serum for the presence of irregular antibodies that could potentially bind to and destroy the donor's red blood cells, leading to a life-threatening hemolytic reaction. Additionally, the direct Coombs test is used to detect the presence of antibodies or complement components already bound to the patient's own red blood cells, which could also indicate an increased risk of a transfusion reaction. By identifying these sensitization factors, Coombs tests allow healthcare providers to select the most compatible blood products for transfusion, minimizing the risk of adverse immune responses and improving patient safety.
2,589 studying →